Should we measure dyspnoea in everyone?

European Respiratory Journal

Volumn 43, Issue 6, 2014, Pages 1547-1550

  Banzett, Robert B ^a,b   O'Donnell, Carl R ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; DYSPNEA; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; LUNG GAS EXCHANGE; MEDICAL DOCUMENTATION; MEDICAL RESEARCH COUNCIL SCALE; MORBIDITY; MORTALITY; PATIENT ATTITUDE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; SYMPTOM; FEMALE; MALE;

DYSPNEA; FEMALE; HUMANS; MALE;

EID: 84901850420     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00031114     Document Type: Editorial

References (34)

1. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185: 435-452.
2. Grønseth R, Vollmer WM, Hardie JA, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J 2014; 43: 1610-1620.
3. Hammond E. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health 1964; 54: 11-23.
4. Kroenke K, Arrington ME, Mangelsdorff AD. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med 1990; 150: 1685-1689. (Pubitemid 20240981)
5. Frostad A, Søyseth V, Andersen A, et al. Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med 2006; 259: 520-529.
6. Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med 1989; 86: 262-266. (Pubitemid 19081465)
7. O'Driscoll M, Corner J, Bailey C. The experience of breathlessness in lung cancer. Eur J Cancer Care (Engl) 1999; 8: 37-43.
8. Currow DC, Abernethy AP, Ko DN. The active identification and management of chronic refractory breathlessness is a human right. Thorax 2014; 69: 393-394.
9. Currow D, Johnson M, White P, et al. Evidence-based intervention for chronic refractory breathlessness: practical therapies that make a difference. Br J Gen Pract 2013; 63: 609-610.
10. Bausewein C, Booth S, Gysels M, et al. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev 2008; 2: CD005623.
11. Booth S, Farquhar M, Gysels M, et al. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: a qualitative phase 1 study. Palliat Support Care 2006; 4: 287-293.
12. Gysels M, Higginson IJ. Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness. J Pain Symptom Manage 2008; 36: 451-460.
13. Roberts DK, Thorne SE, Pearson C. The experience of dyspnea in late-stage cancer. Patients' and nurses' perspectives. Cancer Nurs 1993; 16: 310-320. (Pubitemid 23261130)
14. Max MB. How to move pain and symptom research from the margin to the mainstream. J Pain 2003; 4: 355-360. (Pubitemid 37122575)
15. Laviolette L, Laveneziana P. Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J 2014; 43: 1750-1762.
16. Evans KE, Banzett RB. Neuroimaging of dyspnea. In: Mahler DA, O'Donnell DE, eds. Dyspnea: Mechanisms, Measurement, and Management. 3rd Edn. Boca Raton, CRC Press, 2014.
17. Müllerová H, Lu C, Li H, et al. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One 2014; 9: e85540.
18. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586. (Pubitemid 29296676)
19. Guglin M, Patel T, Darbinyan N. Symptoms in heart failure correlate poorly with objective haemodynamic parameters. Int J Clin Pract 2012; 66: 1224-1229.
20. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440. (Pubitemid 34499652)
21. Abidov A, Rozanski A, Hachamovitch R, et al. Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med 2005; 353: 1889-1898. (Pubitemid 41565954)
22. Djärv T, Metcalfe C, Avery KN, et al. Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer. J Clin Oncol 2010; 28: 1666-1670.
23. Healy LA, Ryan AM, Moore J, et al. Health-related quality of life assessment at presentation may predict complications and early relapse in patients with localized cancer of the esophagus. Dis Esophagus 2008; 21: 522-528.
24. Tessier JF, Nejjari C, Letenneur L, et al. Dyspnea and 8-year mortality among elderly men and women: the PAQUID cohort study. Eur J Epidemiol 2001; 17: 223-229. (Pubitemid 32946298)
25. Tinetti ME, McAvay G, Chang SS, et al. Effect of chronic disease-related symptoms and impairments on universal health outcomes in older adults. J Am Geriatr Soc 2011; 59: 1618-1627.
26. Baker K, Barsamian J, Leone D, et al. Routine dyspnea assessment on unit admission. Am J Nurs 2013; 113: 42-49.
27. Banzett RB, Howell MD, O'Donnell CR, et al. Dyspnea prevalence and risk of adverse event in a general hospital population. Am J Respir Crit Care Med 2013; 187: A2508.
28. Baker K, Stevens J, Anderson L, et al. Dyspnea assessed by nurses every shift - prevalence and risk prediction in a pilot study. Am J Respir Crit Care Med 2014; 189: A1787.
29. Stenton C. The MRC breathlessness scale. Occup Med (Lond) 2008; 58: 226-227.
30. Bausewein C, Booth S, Higginson IJ. Measurement of dyspnoea in the clinical rather than the research setting. Curr Opin Support Palliat Care 2008; 2: 95-99.
31. Dorman S, Byrne A, Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med 2007; 21: 177-191. (Pubitemid 46958244)
32. Yorke J, Moosavi SH, Shuldham C, et al. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010; 65: 21-26.
33. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 2009; 167: 53-60.
34. Meek PM, Banzett R, Parshall MB, et al. Reliability and validity of the multidimensional dyspnea profile. Chest 2012; 141: 1546-1553.